PubRank

David B Dunger

Author PubWeight™ 236.17‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007 19.04
2 Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007 12.62
3 A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 2006 8.65
4 Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet 2010 6.50
5 Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 2007 6.38
6 Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 2004 4.81
7 Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Hum Genet 2005 4.36
8 A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 2004 3.54
9 Early insulin therapy in very-low-birth-weight infants. N Engl J Med 2008 3.51
10 Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies. BMJ 2011 3.36
11 Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst 2002 3.32
12 Poor prognosis of young adults with type 1 diabetes: a longitudinal study. Diabetes Care 2003 2.75
13 Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial. Diabetes Care 2014 2.53
14 Prevalence and determinants of hyperglycemia in very low birth weight infants: cohort analyses of the NIRTURE study. J Pediatr 2010 2.50
15 Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study. BMJ 2008 2.25
16 Size at birth and early childhood growth in relation to maternal smoking, parity and infant breast-feeding: longitudinal birth cohort study and analysis. Pediatr Res 2002 2.22
17 Association of weight gain in infancy and early childhood with metabolic risk in young adults. J Clin Endocrinol Metab 2006 2.15
18 Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 2002 2.12
19 The prevalence of stunting, overweight and obesity, and metabolic disease risk in rural South African children. BMC Public Health 2010 2.08
20 Childhood obesity and the timing of puberty. Trends Endocrinol Metab 2009 2.00
21 Upward weight percentile crossing in infancy and early childhood independently predicts fat mass in young adults: the Stockholm Weight Development Study (SWEDES). Am J Clin Nutr 2006 1.99
22 Genetic markers of adult obesity risk are associated with greater early infancy weight gain and growth. PLoS Med 2010 1.88
23 Early development of adiposity and insulin resistance after catch-up weight gain in small-for-gestational-age children. J Clin Endocrinol Metab 2006 1.87
24 Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial. Diabetes Care 2012 1.84
25 Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes 2011 1.78
26 Insulin sensitivity and secretion are related to catch-up growth in small-for-gestational-age infants at age 1 year: results from a prospective cohort. J Clin Endocrinol Metab 2003 1.70
27 Low IGF-I and elevated testosterone during puberty in subjects with type 1 diabetes developing microalbuminuria in comparison to normoalbuminuric control subjects: the Oxford Regional Prospective Study. Diabetes Care 2003 1.68
28 Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 2007 1.68
29 The relationship of disordered eating habits and attitudes to clinical outcomes in young adult females with type 1 diabetes. Diabetes Care 2005 1.64
30 Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies. J Diabetes Sci Technol 2009 1.63
31 Safety and efficacy of 24-h closed-loop insulin delivery in well-controlled pregnant women with type 1 diabetes: a randomized crossover case series. Diabetes Care 2011 1.57
32 Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes. Diabetes Care 2011 1.57
33 Conscious level in children with diabetic ketoacidosis is related to severity of acidosis and not to blood glucose concentration. Pediatr Diabetes 2006 1.52
34 Effect of oxandrolone and timing of pubertal induction on final height in Turner's syndrome: randomised, double blind, placebo controlled trial. BMJ 2011 1.50
35 The potential impact of the fetal genotype on maternal blood pressure during pregnancy. J Hypertens 2014 1.49
36 Infancy weight gain predicts childhood body fat and age at menarche in girls. J Clin Endocrinol Metab 2009 1.47
37 Simulation environment to evaluate closed-loop insulin delivery systems in type 1 diabetes. J Diabetes Sci Technol 2010 1.47
38 Parental attitudes towards overnight closed-loop glucose control in children with type 1 diabetes. Diabetes Technol Ther 2010 1.46
39 The association between the FTO gene and fat mass in humans develops by the postnatal age of two weeks. J Clin Endocrinol Metab 2008 1.45
40 Anogenital distance from birth to 2 years: a population study. Environ Health Perspect 2009 1.44
41 Hypoglycemia prevalence in prepubertal children with type 1 diabetes on standard insulin regimen: use of continuous glucose monitoring system. Diabetes Care 2003 1.43
42 Dietary energy intake at the age of 4 months predicts postnatal weight gain and childhood body mass index. Pediatrics 2006 1.43
43 The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study. Kidney Int 2005 1.40
44 Evaluation of a portable ambulatory prototype for automated overnight closed-loop insulin delivery in young people with type 1 diabetes. Pediatr Diabetes 2012 1.40
45 Paradoxical elevation of high-molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies. Diabetes 2007 1.35
46 Birth weight, infant growth and insulin resistance. Eur J Endocrinol 2004 1.34
47 Insulin-like growth factor I concentrations in infancy predict differential gains in body length and adiposity: the Cambridge Baby Growth Study. Am J Clin Nutr 2009 1.33
48 Randomized cross-over trial of insulin glargine plus lispro or NPH insulin plus regular human insulin in adolescents with type 1 diabetes on intensive insulin regimens. Diabetes Care 2003 1.27
49 Lessons from large population studies on timing and tempo of puberty (secular trends and relation to body size): the European trend. Mol Cell Endocrinol 2006 1.25
50 Earlier mother's age at menarche predicts rapid infancy growth and childhood obesity. PLoS Med 2007 1.22
51 Evaluating the accuracy and large inaccuracy of two continuous glucose monitoring systems. Diabetes Technol Ther 2012 1.16
52 Nutritional status and HIV in rural South African children. BMC Pediatr 2011 1.15
53 Common polymorphism in H19 associated with birthweight and cord blood IGF-II levels in humans. BMC Genet 2005 1.14
54 Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: common genetic variants in GCK and TCF7L2 are associated with fasting and postchallenge glucose levels in pregnancy and with the new consensus definition of gestational diabetes mellitus from the International Association of Diabetes and Pregnancy Study Groups. Diabetes 2010 1.12
55 Pregnancy insulin, glucose, and BMI contribute to birth outcomes in nondiabetic mothers. Diabetes Care 2008 1.12
56 Automated overnight closed-loop glucose control in young children with type 1 diabetes. Diabetes Technol Ther 2011 1.11
57 Fat distribution in non-obese girls with and without precocious pubarche: central adiposity related to insulinaemia and androgenaemia from prepuberty to postmenarche. Clin Endocrinol (Oxf) 2003 1.11
58 Glucose and lipid metabolism in small for gestational age infants at 48 hours of age. Pediatrics 2003 1.11
59 DNA methylation profiling at imprinted loci after periconceptional micronutrient supplementation in humans: results of a pilot randomized controlled trial. FASEB J 2012 1.11
60 Metformin treatment to prevent early puberty in girls with precocious pubarche. J Clin Endocrinol Metab 2006 1.10
61 Meta-analysis of overnight closed-loop randomized studies in children and adults with type 1 diabetes: the Cambridge cohort. J Diabetes Sci Technol 2011 1.09
62 Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes. Nat Genet 2005 1.09
63 Closed-loop insulin delivery for treatment of type 1 diabetes. BMC Med 2011 1.08
64 Prevalence of abnormal lipid profiles and the relationship with the development of microalbuminuria in adolescents with type 1 diabetes. Diabetes Care 2009 1.08
65 The impact of abnormalities in IGF and inflammatory systems on the metabolic syndrome. Diabetes Care 2004 1.07
66 Metformin therapy during puberty delays menarche, prolongs pubertal growth, and augments adult height: a randomized study in low-birth-weight girls with early-normal onset of puberty. J Clin Endocrinol Metab 2006 1.06
67 Does the fetal genotype affect maternal physiology during pregnancy? Trends Mol Med 2007 1.05
68 Association between insulin-like growth factor-I: insulin-like growth factor-binding protein-1 ratio and metabolic and anthropometric factors in men and women. Cancer Epidemiol Biomarkers Prev 2004 1.04
69 Heritability of childhood weight gain from birth and risk markers for adult metabolic disease in prepubertal twins. J Clin Endocrinol Metab 2009 1.03
70 A1C variability as an independent risk factor for microalbuminuria in young people with type 1 diabetes. Diabetes Care 2011 1.03
71 A longitudinal study of the effects of a gluten-free diet on glycemic control and weight gain in subjects with type 1 diabetes and celiac disease. Diabetes Care 2002 1.03
72 Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes. J Clin Endocrinol Metab 2004 1.03
73 Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment. J Clin Endocrinol Metab 2004 1.02
74 Opposing influences of prenatal and postnatal weight gain on adrenarche in normal boys and girls. J Clin Endocrinol Metab 2004 1.02
75 Sex-discordant associations with adiponectin levels and lipid profiles in children. Diabetes 2006 1.00
76 Anogenital distance and penile length in infants with hypospadias or cryptorchidism: comparison with normative data. Environ Health Perspect 2013 1.00
77 Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism. J Clin Endocrinol Metab 2003 1.00
78 Cell proliferation activities on skin fibroblasts from a short child with absence of one copy of the type 1 insulin-like growth factor receptor (IGF1R) gene and a tall child with three copies of the IGF1R gene. J Clin Endocrinol Metab 2003 0.99
79 Perinatal growth failure: the road to obesity, insulin resistance and cardiovascular disease in adults. Best Pract Res Clin Endocrinol Metab 2002 0.99
80 Early elective insulin therapy can reduce hyperglycemia and increase insulin-like growth factor-I levels in very low birth weight infants. J Pediatr 2007 0.98
81 Higher fasting plasma free fatty acid levels are associated with lower insulin secretion in children and adults and a higher incidence of type 2 diabetes. J Clin Endocrinol Metab 2012 0.96
82 Cross-sectional associations of diet and insulin-like growth factor levels in 7- to 8-year-old children. Cancer Epidemiol Biomarkers Prev 2005 0.96
83 Treatment with recombinant human insulin-like growth factor (rhIGF)-I/rhIGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistance. J Clin Endocrinol Metab 2010 0.95
84 Associations between paternally transmitted fetal IGF2 variants and maternal circulating glucose concentrations in pregnancy. Diabetes 2011 0.94
85 IGF-I treatment of insulin resistance. Eur J Endocrinol 2007 0.93
86 Raised late pregnancy glucose concentrations in mice carrying pups with targeted disruption of H19delta13. Diabetes 2009 0.92
87 Pharmacokinetics of insulin aspart in pump-treated subjects with type 1 diabetes: reproducibility and effect of age, weight, and duration of diabetes. Diabetes Care 2013 0.92
88 Higher levels of IGF-I and adrenal androgens at age 8 years are associated with earlier age at menarche in girls. J Clin Endocrinol Metab 2012 0.92
89 IL-21 production by CD4+ effector T cells and frequency of circulating follicular helper T cells are increased in type 1 diabetes patients. Diabetologia 2015 0.92
90 Validation of ultrasound estimates of visceral fat in black South African adolescents. Obesity (Silver Spring) 2011 0.91
91 Diet throughout childhood and age at menarche in a contemporary cohort of British girls. Public Health Nutr 2010 0.91
92 Low circulating IGF-II concentrations predict weight gain and obesity in humans. Diabetes 2003 0.91
93 Postthymic expansion in human CD4 naive T cells defined by expression of functional high-affinity IL-2 receptors. J Immunol 2013 0.90
94 Insulin resistance is an intrinsic defect independent of fat mass in women with Turner's syndrome. Horm Res 2006 0.89
95 Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetes. J Clin Endocrinol Metab 2004 0.88
96 Maternal-fetal interactions and birth order influence insulin variable number of tandem repeats allele class associations with head size at birth and childhood weight gain. Diabetes 2004 0.88
97 Insulin administration and rate of glucose appearance in people with type 1 diabetes. Diabetes Care 2008 0.88
98 Effects of recombinant human IGF-I/IGF-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetes. Diabetes 2006 0.87
99 Effect of acute variations of insulin and glucose on plasma concentrations of asymmetric dimethylarginine in young people with Type 1 diabetes. Clin Sci (Lond) 2008 0.86
100 What is the best management strategy for patients with severe insulin resistance? Clin Endocrinol (Oxf) 2010 0.85
101 Traumatic brain injury is a rarely reported cause of growth hormone deficiency. J Pediatr 2008 0.85
102 Breastfeeding and infant temperament at age three months. PLoS One 2012 0.85
103 Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency. Clin Endocrinol (Oxf) 2005 0.84
104 Effects of growth hormone and free fatty acids on insulin sensitivity in patients with type 1 diabetes. J Clin Endocrinol Metab 2009 0.84
105 Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation. J Clin Endocrinol Metab 2002 0.84
106 Future directions: growth prediction models. Horm Res 2007 0.84
107 C-reactive protein in relation to the development of microalbuminuria in type 1 diabetes: the Oxford Regional Prospective Study. Diabetes Care 2008 0.84
108 Lack of association between common polymorphisms in the 17beta-hydroxysteroid dehydrogenase type V gene (HSD17B5) and precocious pubarche. J Steroid Biochem Mol Biol 2007 0.83
109 Symmetric dimethylarginine, an endogenous marker of glomerular filtration rate, and the risk for microalbuminuria in young people with type 1 diabetes. Arch Dis Child 2009 0.83
110 Ultrasound estimates of visceral and subcutaneous-abdominal adipose tissues in infancy. J Obes 2013 0.83
111 Status and rationale of renoprotection studies in adolescents with type 1 diabetes. Pediatr Diabetes 2009 0.83
112 Insulin and carbohydrate metabolism. Best Pract Res Clin Endocrinol Metab 2008 0.83
113 The role of inflammatory pathway genetic variation on maternal metabolic phenotypes during pregnancy. PLoS One 2012 0.83
114 Common polymorphic variation in the genetically diverse African insulin gene and its association with size at birth. Hum Genet 2009 0.83
115 Maternally transmitted foetal H19 variants and associations with birth weight. Hum Genet 2011 0.83
116 Association between a common variant near MC4R and change in body mass index develops by two weeks of age. Horm Res Paediatr 2010 0.83
117 Polycystic ovarian syndrome during puberty and adolescence. Mol Cell Endocrinol 2013 0.82
118 Plasminogen activator inhibitor-1 in girls with precocious pubarche: a premenarcheal marker for polycystic ovary syndrome? Pediatr Res 2002 0.82
119 Application of Intervention Mapping to develop a community-based health promotion pre-pregnancy intervention for adolescent girls in rural South Africa: Project Ntshembo (Hope). BMC Public Health 2014 0.82
120 Increasing urine albumin excretion is associated with growth hormone hypersecretion and reduced clearance of insulin in adolescents and young adults with type 1 diabetes: the Oxford Regional Prospective Study. Clin Endocrinol (Oxf) 2005 0.82
121 Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT): urinary screening and baseline biochemical and cardiovascular assessments. Diabetes Care 2013 0.82
122 No evidence for a major effect of two common polymorphisms of the catalase gene in type 1 diabetes susceptibility. Diabetes Metab Res Rev 2006 0.82
123 Pharmacokinetics of diluted (U20) insulin aspart compared with standard (U100) in children aged 3-6 years with type 1 diabetes during closed-loop insulin delivery: a randomised clinical trial. Diabetologia 2014 0.81
124 Flutamide metformin for post-menarcheal girls with preclinical ovarian androgen excess: evidence for differential response by androgen receptor genotype. Eur J Endocrinol 2007 0.81
125 The somatotropic axis in short children born small for gestational age: relation to insulin resistance. Pediatr Res 2002 0.80
126 Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX. Expert Opin Drug Metab Toxicol 2008 0.80
127 Plasma concentrations of soluble IL-2 receptor α (CD25) are increased in type 1 diabetes and associated with reduced C-peptide levels in young patients. Diabetologia 2013 0.80
128 Insulin Receptor and the Kidney: Nephrocalcinosis in Patients with Recessive INSR Mutations. Nephron Physiol 2014 0.80
129 Metabolic response to 36 hours of fasting in young men born small vs appropriate for gestational age. Diabetologia 2014 0.80
130 Implications of adopting the WHO 2006 Child Growth Standards: case study from urban South Africa, the Birth to Twenty cohort. Ann Hum Biol 2008 0.79
131 Intramyocellular lipid levels are associated with peripheral, but not hepatic, insulin sensitivity in normal healthy subjects. Clin Sci (Lond) 2009 0.79
132 The insulin gene variable number of tandem repeat: associations and interactions with childhood body fat mass and insulin secretion in normal children. J Clin Endocrinol Metab 2006 0.79
133 Relationships of urinary adrenal steroids at age 8 years with birth weight, postnatal growth, blood pressure, and glucose metabolism. J Clin Endocrinol Metab 2007 0.79
134 Impact of treatment with recombinant human GH and IGF-I on visceral adipose tissue and glucose homeostasis in adults. Growth Horm IGF Res 2006 0.79
135 Hyperglycemia in the newborn--clinical guidelines are needed but must be based on correct reporting of the data. JPEN J Parenter Enteral Nutr 2012 0.78
136 Associations between common variation in the aromatase gene promoter region and testosterone concentrations in two young female populations. J Steroid Biochem Mol Biol 2006 0.78
137 Growth hormone binding protein levels in children are associated with birth weight, postnatal weight gain, and insulin secretion. Metabolism 2007 0.78
138 Genetic variation in the type 2 insulin-like growth factor receptor gene and disparity in childhood height. Growth Horm IGF Res 2005 0.78
139 Effects of growth hormone treatment on neutrophil count in children born small for gestational age. Pediatrics 2006 0.78
140 Therapeutic applications of the insulin-like growth factors. Growth Horm IGF Res 2004 0.78
141 Peripubertal changes in circulating antimüllerian hormone levels in girls. Fertil Steril 2013 0.78
142 Individual igf-I responsiveness to a fixed regimen of low-dose growth hormone replacement is increased with less variability in obese compared to non-obese adults with severe growth hormone deficiency. Horm Res 2005 0.77
143 Will the use of insulin analogs improve glycemic control during adolescence? Pediatr Diabetes 2003 0.77
144 Low circulating levels of IGF-1 in healthy adults are associated with reduced β-cell function, increased intramyocellular lipid, and enhanced fat utilization during fasting. J Clin Endocrinol Metab 2014 0.77
145 Effect of oxandrolone and timing of oral ethinylestradiol initiation on pubertal progression, height velocity and bone maturation in the UK Turner study. Horm Res Paediatr 2014 0.77
146 Pegvisomant: current and potential novel therapeutic applications. Expert Opin Biol Ther 2009 0.77
147 Normal Variation in Pubertal Timing: Genetic Determinants in Relation to Growth and Adiposity. Endocr Dev 2015 0.77
148 Insulin resistance after precocious pubarche: relation to PAI-1-675 4G/5G polymorphism, and opposing influences of prenatal and postnatal weight gain. Clin Endocrinol (Oxf) 2007 0.76
149 Closed-loop in children with type 1 diabetes: specific challenges. Diabetes Res Clin Pract 2011 0.76
150 Maternal but not paternal association of ambulatory blood pressure with albumin excretion in young offspring with type 1 diabetes. Diabetes Care 2009 0.76
151 Baseline IGF-I levels determine insulin secretion and insulin sensitivity during the first year on growth hormone therapy in children born small for gestational age. Results from a North European Multicentre Study (NESGAS). Horm Res Paediatr 2013 0.76
152 An independent effect of parental lipids on the offspring lipid levels in a cohort of adolescents with type 1 diabetes. Pediatr Diabetes 2012 0.76
153 Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency. Clin Endocrinol (Oxf) 2006 0.76
154 Complications of type 1 diabetes in adolescents. BMJ 2008 0.75
155 Hirsutism. N Engl J Med 2006 0.75
156 Ghrelin receptor gene polymorphisms and body size in children and adults. J Clin Endocrinol Metab 2008 0.75
157 Increased placental glucose transport rates in pregnant mice carrying fetuses with targeted disruption of their placental-specific Igf2 transcripts are not associated with raised circulating glucose concentrations. Exp Diabetes Res 2011 0.75
158 Persisting benefits 12-18 months after discontinuation of pubertal metformin therapy in low birthweight girls. Clin Endocrinol (Oxf) 2007 0.75
159 Predictors of Insulin-Like Growth Factor-I Responses to Growth Hormone Replacement in Young Adults with Growth Hormone Deficiency. Horm Res Paediatr 2016 0.75
160 Effect of delay on measurement of blood glucose levels in young subjects with type 1 diabetes. Diabetes Res Clin Pract 2009 0.75
161 Genetic markers of insulin sensitivity and insulin secretion are associated with spontaneous postnatal growth and response to growth hormone treatment in short SGA children: the North European SGA Study (NESGAS). J Clin Endocrinol Metab 2014 0.75
162 Erratum to: Metabolic response to 36 hours of fasting in young men born small vs appropriate for gestational age. Diabetologia 2015 0.75
163 Genetics in growth, and pituitary tumorigenesis. Preface. Horm Res 2009 0.75
164 Type 1 diabetes in children: a review. Practitioner 2005 0.75
165 The contribution of glycemic control to impaired growth during puberty in young people with type 1 diabetes and microalbuminuria. Pediatr Diabetes 2013 0.75
166 Baseline Characteristics and Gender Differences in Prepubertal Children Treated with Growth Hormone in Europe, USA, and Japan: 25 Years' KIGS® Experience (1987-2012) and Review. Horm Res Paediatr 2016 0.75
167 Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates. Clin Endocrinol (Oxf) 2006 0.75
168 Erratum. Blood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1 Diabetes. Diabetes 2014;63:3835-3845. Diabetes 2015 0.75